Attached files

file filename
10-Q - FORM 10-Q QUARTERLY REPORT FOR 06-30-2021 - REPRO MED SYSTEMS INCkrmd-20210630_form10q.htm
EX-32 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - REPRO MED SYSTEMS INCex_32-1.htm
EX-31 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - REPRO MED SYSTEMS INCex_31-2.htm
EX-31 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - REPRO MED SYSTEMS INCex_31-1.htm
EX-10 - FORM OF INDEMNIFICATION AGMT. DIRECTORS & EXECUTIVE OFFICERS - REPRO MED SYSTEMS INCex_10-4.htm
EX-10 - FORM OF NON-QUALIFIED/INCENTIVE STOCK OPTION AWARD AGREEMENT - REPRO MED SYSTEMS INCex_10-3.htm
EX-10 - REPRO MED SYSTEMS, INC. 2021 OMNIBUS EQUITY INCENTIVE PLAN - REPRO MED SYSTEMS INCex_10-2.htm
EX-10 - SUMMARY OF NON-EMPLOYEE DIRECTOR COMPENSATION - REPRO MED SYSTEMS INCex_10-1.htm

 

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADDED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Repro Med Systems, Inc. (the “Company”) on Form 10-Q (the “Report”) for the quarter ended June 30, 2021 as filed with the Securities and Exchange Commission, I, Karen Fisher, Principal Financial Officer, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
     
  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: August 11, 2021

 

/s/ Karen Fisher

Karen Fisher

Chief Financial Officer and Treasurer